Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
about
Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test - Demonstrated in vitro and ex vivo.Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity.Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETP.Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents.Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.
P2860
Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Thrombin generation as objecti ...... a A and high-titre inhibitors.
@en
Thrombin generation as objecti ...... a A and high-titre inhibitors.
@nl
type
label
Thrombin generation as objecti ...... a A and high-titre inhibitors.
@en
Thrombin generation as objecti ...... a A and high-titre inhibitors.
@nl
prefLabel
Thrombin generation as objecti ...... a A and high-titre inhibitors.
@en
Thrombin generation as objecti ...... a A and high-titre inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Thrombin generation as objecti ...... a A and high-titre inhibitors.
@en
P2093
A Bergés-García
A R Jaloma-Cruz
C P Beltrán-Miranda
J Soto-Padilla
M A Esparza-Flores
M D C Rodríguez-Zepeda
M T Pompa-Garza
P2860
P356
10.1111/HAE.12309
P577
2014-01-01T00:00:00Z